169 related articles for article (PubMed ID: 37103624)
21. Diagnosis of dysthyroid optic neuropathy: combined value of orbital MRI and intracranial visual pathway diffusion kurtosis imaging.
Hu H; Zhou J; Jiang WH; Wu Q; Pu XY; Liu H; Chen HH; Xu XQ; Wu FY
Eur Radiol; 2024 Jan; ():. PubMed ID: 38276980
[TBL] [Abstract][Full Text] [Related]
22. The diagnostic value of the IDEAL-T2WI sequence in dysthyroid optic neuropathy: a quantitative analysis of the optic nerve and cerebrospinal fluid in the optic nerve sheath.
Wu H; Luo B; Yuan G; Wang Q; Liu P; Zhao Y; Zhai L; Ma Y; Lv W; Zhang J
Eur Radiol; 2021 Oct; 31(10):7419-7428. PubMed ID: 33993334
[TBL] [Abstract][Full Text] [Related]
23. Computerized colour vision testing.
Ing EB; Parker JA; Emerton LA
Can J Ophthalmol; 1994 Jun; 29(3):125-8. PubMed ID: 7922851
[TBL] [Abstract][Full Text] [Related]
24. Multiparametric quantitative MRI for the evaluation of dysthyroid optic neuropathy.
Zou M; Wu D; Zhu H; Huang X; Zhao X; Zhao J; Fu W; Li R; Li B; Wan P; Hong S; Li Y; Xiao H; Yang Z
Eur Radiol; 2022 Mar; 32(3):1931-1938. PubMed ID: 34642808
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the Waggoner Computerized Color Vision Test.
Ng JS; Self E; Vanston JE; Nguyen AL; Crognale MA
Optom Vis Sci; 2015 Apr; 92(4):480-6. PubMed ID: 25785530
[TBL] [Abstract][Full Text] [Related]
26. Extraocular muscle volume index at the orbital apex with optic neuritis: a combined parameter for diagnosis of dysthyroid optic neuropathy.
Song C; Luo Y; Huang W; Duan Y; Deng X; Chen H; Yu G; Huang K; Xu S; Lin X; Wang Y; Shen J
Eur Radiol; 2023 Dec; 33(12):9203-9212. PubMed ID: 37405499
[TBL] [Abstract][Full Text] [Related]
27. Predicting the CN Lantern Test for Railways with Clinical Color-vision Tests.
Almustanyir A; Hovis JK
Optom Vis Sci; 2020 May; 97(5):332-339. PubMed ID: 32413004
[TBL] [Abstract][Full Text] [Related]
28. Peripapillary and Macular Vessel Density in Dysthyroid Optic Neuropathy: An Optical Coherence Tomography Angiography Study.
Zhang T; Xiao W; Ye H; Chen R; Mao Y; Yang H
Invest Ophthalmol Vis Sci; 2019 May; 60(6):1863-1869. PubMed ID: 31042792
[TBL] [Abstract][Full Text] [Related]
29. Detection of color vision defects in chloroquine retinopathy.
Vu BL; Easterbrook M; Hovis JK
Ophthalmology; 1999 Sep; 106(9):1799-803; discussion 1804. PubMed ID: 10485553
[TBL] [Abstract][Full Text] [Related]
30. [Peripapillary and macular vessel density in eyes with different phases of thyroid-associated ophthalmopathy].
Wang YH; Ma J; Li H; Xu HY; Gan LY; Zhang X; Wang XQ; Zhong Y
Zhonghua Yan Ke Za Zhi; 2020 Nov; 56(11):824-831. PubMed ID: 33152840
[No Abstract] [Full Text] [Related]
31. A method for identifying color vision deficiency malingering.
Pouw A; Karanjia R; Sadun A
Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):613-618. PubMed ID: 28004196
[TBL] [Abstract][Full Text] [Related]
32. Flow Changes in Orbital Vessels Detected with Color Doppler Ultrasound in Patients with Early Dysthyroid Optic Neuropathy.
Lešin M; Rogošić V; Vanjaka Rogošić L; Barišić I; Pelčić G
Acta Clin Croat; 2018 Jun; 57(2):301-306. PubMed ID: 30431723
[TBL] [Abstract][Full Text] [Related]
33. Performance of red-green color deficient subjects on the Holmes-Wright lantern (Type A) in photopic viewing.
Birch J
Aviat Space Environ Med; 1999 Sep; 70(9):897-901. PubMed ID: 10503756
[TBL] [Abstract][Full Text] [Related]
34. Use of the Mollon-Reffin minimalist color vision test with young children.
Shute RH; Westall CA
J AAPOS; 2000 Dec; 4(6):366-72. PubMed ID: 11124673
[TBL] [Abstract][Full Text] [Related]
35. Dysthyroid optic neuropathy: evaluation and management.
Dolman PJ
J Endocrinol Invest; 2021 Mar; 44(3):421-429. PubMed ID: 32729049
[TBL] [Abstract][Full Text] [Related]
36. Selective deficits of S-cone in thyroid-associated ophthalmopathy patients without clinical signs of dysthyroid optic neuropathy.
Jin H; Yu X; Cao S; Wang M; Hu X; Ye J; Liu W; Xu M; Wu W; Tu Y
Front Neurosci; 2022; 16():990425. PubMed ID: 36213732
[TBL] [Abstract][Full Text] [Related]
37. [Therapeutic outcomes and influence factors of maximal orbital decompression in the treatment of severe dysthyroid optic neuropathy].
Wang Y; Li YY; Yang N; Ma R; Xiao LH
Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):416-423. PubMed ID: 28606262
[TBL] [Abstract][Full Text] [Related]
38. Optic neuropathy in thyroid eye disease: results of the balanced decompression technique.
Baril C; Pouliot D; Molgat Y
Can J Ophthalmol; 2014 Apr; 49(2):162-6. PubMed ID: 24767222
[TBL] [Abstract][Full Text] [Related]
39. Implications of inherited color vision deficiency on occupations: A neglected entity!
Hathibelagal AR
Indian J Ophthalmol; 2022 Jan; 70(1):256-260. PubMed ID: 34937250
[TBL] [Abstract][Full Text] [Related]
40. Clinical and soft-tissue computed tomographic predictors of dysthyroid optic neuropathy: refinement of the constellation of findings at presentation.
Weis E; Heran MK; Jhamb A; Chan AK; Chiu JP; Hurley MC; Rootman J
Arch Ophthalmol; 2011 Oct; 129(10):1332-6. PubMed ID: 21987676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
